← Back to Search

Cognitive Stimulation Therapy for Dementia

N/A
Waitlist Available
Led By Michael Lepore, PhD
Research Sponsored by University of Massachusetts, Amherst
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Mild Cognitive Impairment or Mild to Moderate Dementia
Be older than 18 years old
Must not have
Patient has specified to HCS not to engage patient in research or to use patient data in research
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months

Summary

This trial will determine if V-CST can help people with mild to moderate dementia, by comparing cognitive decline between those who participate in V-CST and those who don't.

Who is the study for?
This trial is for English-speaking individuals with mild to moderate dementia, as indicated by certain cognitive test scores. They must have a scheduled visit for cognitive screening within 6-12 months and not have participated in V-CST before. Those without online access or necessary caregiver support, or who have impairments that interfere with group therapy are excluded.
What is being tested?
The trial tests if Cognitive Stimulation Therapy (CST) delivered virtually can slow down cognitive decline in dementia patients compared to standard care. Participants will be randomly assigned to either receive a referral for virtual CST or continue with their usual treatment without changes.
What are the potential side effects?
Since the intervention involves non-pharmacological therapy, traditional side effects associated with medications are not expected. However, participants may experience discomfort from using technology or feelings of frustration if they find the sessions challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with mild cognitive impairment or mild to moderate dementia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have chosen not to participate in research or share my data for research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognitive decline measured by an increase in Montreal Cognitive Assessment Score from baseline to follow-up
Secondary study objectives
Cognitive improvement measured by a decrease in Montreal Cognitive Assessment Score from baseline to follow-up
Participant Attrition
Participant attendance
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Referral for Cognitive Stimulation TherapyActive Control1 Intervention
This group will receive a referral from their physician for CST treatment
Group II: Standard of CarePlacebo Group1 Intervention
This group will receive standard of care and no CST referral.

Find a Location

Who is running the clinical trial?

University of Massachusetts, AmherstLead Sponsor
81 Previous Clinical Trials
468,017 Total Patients Enrolled
UConn HealthOTHER
215 Previous Clinical Trials
60,588 Total Patients Enrolled
Yale UniversityOTHER
1,930 Previous Clinical Trials
3,033,341 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,804 Previous Clinical Trials
28,194,766 Total Patients Enrolled
University of Maryland, BaltimoreOTHER
716 Previous Clinical Trials
380,981 Total Patients Enrolled
Michael Lepore, PhDPrincipal InvestigatorUniversity of Massachusetts, Amherst

Media Library

Cognitive Stimulation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05860127 — N/A
Vascular Dementia Research Study Groups: Standard of Care, Referral for Cognitive Stimulation Therapy
Vascular Dementia Clinical Trial 2023: Cognitive Stimulation Therapy Highlights & Side Effects. Trial Name: NCT05860127 — N/A
Cognitive Stimulation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860127 — N/A
Vascular Dementia Patient Testimony for trial: Trial Name: NCT05860127 — N/A
~31 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top